Victrix Investment Advisors Purchases Shares of 1,151 Oracle Corporation $ORCL

Victrix Investment Advisors purchased a new stake in Oracle Corporation (NYSE:ORCL) during the 2nd quarter, Holdings Channel reports. The firm purchased 1,151 shares of the enterprise software provider’s stock, valued at approximately $252,000.

A number of other hedge funds have also made changes to their positions in ORCL. Brighton Jones LLC increased its stake in shares of Oracle by 189.3% during the fourth quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock valued at $25,593,000 after acquiring an additional 100,494 shares during the period. Revolve Wealth Partners LLC increased its stake in shares of Oracle by 8.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock valued at $903,000 after acquiring an additional 404 shares during the period. Gradient Investments LLC increased its stake in shares of Oracle by 3.5% during the first quarter. Gradient Investments LLC now owns 76,802 shares of the enterprise software provider’s stock valued at $10,738,000 after acquiring an additional 2,572 shares during the period. Baxter Bros Inc. increased its stake in shares of Oracle by 13.7% during the first quarter. Baxter Bros Inc. now owns 2,030 shares of the enterprise software provider’s stock valued at $284,000 after acquiring an additional 245 shares during the period. Finally, Affiance Financial LLC increased its stake in shares of Oracle by 2.1% during the first quarter. Affiance Financial LLC now owns 5,210 shares of the enterprise software provider’s stock valued at $728,000 after acquiring an additional 106 shares during the period. Institutional investors and hedge funds own 42.44% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on ORCL shares. TD Cowen raised their price objective on shares of Oracle from $325.00 to $375.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. Oppenheimer restated an “outperform” rating on shares of Oracle in a report on Wednesday, June 18th. Bank of America upgraded shares of Oracle from a “neutral” rating to a “buy” rating and raised their target price for the stock from $295.00 to $368.00 in a report on Wednesday, September 10th. Guggenheim raised their target price on shares of Oracle from $250.00 to $375.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Finally, Sanford C. Bernstein raised their target price on shares of Oracle from $363.00 to $364.00 and gave the stock an “outperform” rating in a report on Friday, September 26th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $304.71.

Insider Activity at Oracle

In other Oracle news, Director William G. Parrett sold 11,500 shares of Oracle stock in a transaction on Friday, September 12th. The shares were sold at an average price of $306.00, for a total transaction of $3,519,000.00. Following the completion of the sale, the director owned 17,764 shares of the company’s stock, valued at $5,435,784. This trade represents a 39.30% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Rona Alison Fairhead bought 480 shares of the firm’s stock in a transaction on Monday, July 7th. The shares were bought at an average cost of $233.87 per share, with a total value of $112,257.60. Following the purchase, the director directly owned 22,110 shares in the company, valued at approximately $5,170,865.70. This trade represents a 2.22% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 114,314 shares of company stock worth $33,602,123. 42.20% of the stock is currently owned by company insiders.

Oracle Stock Down 0.6%

NYSE:ORCL opened at $281.01 on Wednesday. The firm has a market capitalization of $801.10 billion, a price-to-earnings ratio of 65.05, a PEG ratio of 3.04 and a beta of 1.46. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $345.72. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33. The business’s fifty day moving average price is $259.82 and its 200 day moving average price is $202.64.

Oracle (NYSE:ORCL) last posted its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). The business had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, sell-side analysts forecast that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. Oracle’s dividend payout ratio (DPR) is 46.30%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.